Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Previously Treated Patients with HER2-Mutant Advanced NSCLC. Show all posts
Showing posts with label Previously Treated Patients with HER2-Mutant Advanced NSCLC. Show all posts
Tuesday, December 16, 2025

FDA Grants Accelerated Approval to Hernexeos (zongertinib) for Previously Treated Patients with HER2-Mutant Advanced NSCLC

›
Boehringer Ingelheim’s Hernexeos (zongertinib tablets) has been approved by the U.S. Food and Drug Administration (FDA). The kinase inhibito...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.